ライフサイエンスコーパス: M. hominis

1 donor for patient 1, which subsequently grew M. hominis.

2 d to 24 (29.6%) of the 81 women negative for M. hominis.

3 a suggest donor-to-recipient transmission of M. hominis.

4 mutator element in the vaa gene that governs M. hominis adherence and highlight the importance of mut

5 T. vaginalis in symbiosis with M. hominis or M. hominis alone triggers a noncanonical type I interfer

6 Increasing levels of G. vaginalis and M. hominis and decreasing levels of lactobacilli were si

7 ergence of Vaa could affect the adherence of M. hominis and evasion of antibody-mediated immunity, th

8 he results of these studies demonstrate that M. hominis and M. hominis antigen are potent stimulators

9 acteria will not be reliable for recovery of M. hominis and that specialized media and incubation con

10 ase demonstrates the pathogenic potential of M. hominis and the need for rapid recognition of the org

11 hree log(10) bacterial counts (G. vaginalis, M. hominis, and lactobacilli) in our model improved the

12 hese studies demonstrate that M. hominis and M. hominis antigen are potent stimulators of type II epi

13 erial vaginosis was strongly associated with M. hominis (aOR = 8.01, 95%CI:5.99-10.71), but was not a

14 tative bacterial counts for lactobacilli and M. hominis are better correlates of CVL HIV RNA than are

15 m the joint synovial fluid of a patient with M. hominis-associated arthritis, which indicated that Va

16 terial counts (P=.006; inverse association), M. hominis bacterial counts (P=.0001; positive associati

17 ate analyses, we found that G. vaginalis and M. hominis bacterial counts, Candida vaginitis, and herp

18 Clinicians should be aware that M. hominis can cause surgical site infections, and may n

19 had log(10) G. vaginalis counts and log(10) M. hominis counts greater than 6.81 and 4.82, respective

20 Here we describe the recovery of M. hominis from a brain abscess associated with a postpa

21 PCR quantification of G. vaginalis and M. hominis from CVL is significantly more sensitive than

22 e to challenge with LPS, U. urealyticum, and M. hominis in a concentration-dependent fashion.

23 No BacT/ALERT bottles containing M. hominis in simulated blood cultures were flagged posi

24 e data strongly suggest that the presence of M. hominis in the lungs of premature infants may initiat

25 Surfactant suppressed LPS and M. hominis induced TNF-alpha production in a dose-depend

26 ng chronic, active arthritis associated with M. hominis infection and is highly immunogenic in the hu

27 cated that Vaa phase variation occurs during M. hominis infection in the natural host.

28 ransplant recipients presented with invasive M. hominis infections at multiple sites characterized by

29 In a single center, a cluster of M. hominis infections were identified in lung transplant

30 eloped surgical site infections, including 2 M. hominis infections.

31 ICU were found to have genetically unrelated M. hominis isolates, excluding patient-to-patient transm

32 The M. hominis-like mycoplasma neither inhibits nor enhances

33 Evidence for M. hominis neutrophil extracellular trap escape is also

34 Only 7 women were positive for M. hominis; none were allele 2 homozygotes as opposed to

35 nfection with T. vaginalis in symbiosis with M. hominis or M. hominis alone triggers a noncanonical t

36 Mechanisms of M. hominis pathogenicity are still largely obscure, and

37 We investigated a cluster of M. hominis surgical site infections in patients who unde

38 ich correlated precisely with the ability of M. hominis to adhere to cultured human cells.

39 findings do not support routine testing for M. hominis, U. urealyticum, and U. parvum in nonpregnant

40 We investigated if M. hominis, U. urealyticum, and U. parvum were associate

41 lvovaginal candidiasis (VVC), and tested for M. hominis, U. urealyticum, and U. parvum, and 4 nonvira

42 immunity and provide additional knowledge on M. hominis virulence and survival in the host.

43 n requirements and relatively slow growth of M. hominis warrant that dependence on automated systems

44 After adjusting for STIs and VVC, M. hominis was associated with abnormal vaginal discharg

45 In stratified analyses, M. hominis was associated with self-reported vaginal mal

46 Only M. hominis was associated with symptoms/signs, and these

47 s, Ureaplasma spp. was detected in 23 (82%), M. hominis was detected in 3 (11%), and both were detect

48 Viability of clinical isolates of M. hominis was maintained for 7 days in BacT/ALERT media

49 Importantly, M. hominis was not associated with symptoms/signs in wom